Search

Author/Creator Suh, J H

1. DOP62 A novel formulation of CT-P13 (infliximab biosimilar) for subcutaneous administration: 1-year result from a Phase I open-label randomised controlled trial in patients with active Crohn's disease. (25th January 2019)

Authors:
Reinisch, W; Jang, B I; Borzan, V; Lahat, A; Pukitis, A; Osipenko, M; Mostovoy, Y; Schreiber, S; Ben-Horin, S; Lee, S J; Suh, J H; Lee, S G; Lee, J H; Ye, B D
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S066
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P15.11.A 18F-Fluciclovine PET/CT to distinguish radiation necrosis from tumour progression in brain metastases treated with stereotactic radiosurgery: results of a prospective pilot study. (5th September 2022)

Authors:
Tom, M C; DiFilippo, F; Smile, T; Jones, S E; Suh, J H; Murphy, E S; Yu, J S; Mohammadi, A M; Barnett, G H; Angelov, L; Huang, S S; Wu, G; Johnson, S; Obuchowski, N; Ahluwalia, M; Peereboom, D; Stevens, G; Chao, S
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 2
Page Start:
ii86
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P679 Development of a novel auto-injector of subcutaneous CT-P13 infliximab: Phase I randomised, open-label, single-dose trial to compare the pharmacokinetics and safety to pre-filled syringe in healthy subjects. (25th January 2019)

Authors:
Schreiber, S; Ben-Horin, S; Ye, B D; Westhovens, R; Yoo, D H; Lee, S J; Suh, J H; Byeon, J H; Reinisch, W
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S458
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗